Canaccord Genuity Starts Intersect ENT (XENT) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts XENT Hot Sheet
Price: $28.24 --0%
Rating Summary:
4 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 12
Rating Summary:
4 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 21 | New: 12
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Intersect ENT (NASDAQ: XENT) with a Buy rating and a price target of $27.00.
For an analyst ratings summary and ratings history on Intersect ENT click here. For more ratings news on Intersect ENT click here.
Shares of Intersect ENT closed at $23.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Capital Starts AIB Data Centers (AIB) at Buy
- Sidoti Starts Huize (HUIZ) at Neutral
- Phillip Securities Starts Pinterest Inc (PINS) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
